InterStim Basic Evaluation Lead Post-Market Clinical Follow-up Study

NACompletedINTERVENTIONAL
Enrollment

110

Participants

Timeline

Start Date

November 28, 2019

Primary Completion Date

October 6, 2020

Study Completion Date

October 9, 2020

Conditions
Overactive BladderUrinary Urge IncontinenceUrgency-frequency Syndrome
Interventions
DEVICE

InterStim Basic Evaluation lead and foramen needle

Commercial devices within their intended use as described in approved Instructions for Use.

Trial Locations (15)

28345

FirstHealth Urogynecology, Hamlet

33606

Florida Urology Partners, Tampa

33710

Pinellas Urology, St. Petersburg

55441

Minnesota Urology (Plymouth), Plymouth

76017

Urology Partners of North Texas, Arlington

07631

Urologic Research and Consulting, Englewood

45234-2640

Wright State Physicians, Fairborn

29605-4627

Prisma Health, Greenville

29169-3456

Southern Urogynecology, West Columbia

23642-1815

Urology of Virginia, Virginia Beach

M5T 2S8

University Urology Associates, Toronto

6525 GA

Radboud UMC, Nijmegen

BS10 5NB

The Bristol Urological Institute, Bristol

NE7 7DN

The Newcastle upon Tyne Hospitals, Newcastle upon Tyne

M68HD

Salford Royal NHS Foundation Trust, Salford

Sponsors

Lead Sponsor

All Listed Sponsors
lead

MedtronicNeuro

INDUSTRY